AllPennyStocks.com Best Value Stocks to Buy for August 7th
This section contains press releases and other materials from third parties (including paid content). AllPennyStocks.com has not reviewed this content. Please see our disclaimer.

Best Value Stocks to Buy for August 7th

Here are three stocks with buy rank and strong value characteristics for investors to consider today, August 7:

California BanCorp BCAL: This bank holding company for California Bank of Commerce carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its next year earnings increasing 5% over the last 60 days.

California Bank has a price-to-earnings ratio (P/E) of 12.23, compared with 12.50 for the industry. The company possesses a Value Score of B.

Supernus Pharmaceuticals, Inc. SUPN: This biopharmaceutical company focused on CNS diseases carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.6% over the last 60 days.

Supernus has a price-to-earnings ratio (P/E) of 17.54, compared with 23.54 for the S&P 500. The company possesses a Value Score of B.

NexPoint Residential Trust, Inc. NXRT: This publicly traded REIT carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 9.3% over the last 60 days.

NexPoint Residential has a price-to-earnings ratio (P/E) of 10.51, compared with 17.30 for the industry. The company possesses a Value Score of B.

 

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

 

Learn more about the Value score and how it is calculated here.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Supernus Pharmaceuticals, Inc. (SUPN): Free Stock Analysis Report
 
NexPoint Residential Trust, Inc. (NXRT): Free Stock Analysis Report
 
California BanCorp (BCAL): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Other Penny Stock Movers

When Design Thinking Meets the AI Canvas
Brazilian Developer Jumps 11% as Court Lifts Injunction
Deep Utah Porphyry Intercept Triggers 57% Rally as Drilling Continues Past 550m
Most Popular
{{ index + 1 }}


Back to Top